Annexin appoints Dr. Mario Fsadni as Head of Ophthalmology
Annexin Pharmaceuticals AB (publ) announces that Dr Mario Fsadni, an ophthalmologist with extensive global experience from leading novel compounds through clinical development into marketed drugs, will join as a new team member and Therapy Area Head, Ophthalmology.STOCKHOLM (29 March, 2022) - Dr. Fsadni, MBChB, MRC Ophth, MSc, LLM, FMH has obtained his Medical Degree and Ophthalmology training in Manchester, UK. He was previously the Global Medical Director at Novartis Ophthalmics and Director Product Development in Ophthalmology at Allergan, before starting a consultancy designed